fr   en

Browse by date
Or search by keyword
Date: 2010-06-11
Company: Mologen (Germany)
Investors: institutional investors
Amount: € 4.3 million
Planned use: The funds will be specifically invested in clinical development programs for cancer medications.
Other: Mologen has completed its capital increase against cash contributions and excluding subscription rights. the company placed 500,000 new ordinary bearer shares (around 5% of
the total share capital) with institutional investors - each at a value of 8.50 euro.
The registration of the capital increase with the respective commercial register is currently under
preparation. After the inclusion of this increase the share capital of Mologen totals
11,158,348 euro.